{"transactions":[{"id":6187,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Nqso (Right to Buy)","published_at":"2026-08-07T22:45:54.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2948,"derivative":{"exercise_price":177.31,"exercise_date":"2021-05-03","expiration_date":"2029-05-03","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000318154-26-000129","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000129/form4.xml","form_type":"4"}},{"id":6186,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Nqso (Right to Buy)","published_at":"2026-08-07T22:45:54.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":false,"shares":1970,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":177.46,"exercise_date":"2020-04-27","expiration_date":"2028-04-27","underlying":"Common Stock","underlying_shares":1970},"source":{"system":"sec-edgar","filing":"0000318154-26-000129","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000129/form4.xml","form_type":"4"}},{"id":6185,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2026-08-07T22:45:54.000Z","date":"2026-08-06","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":402.1601,"value":402160.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes shares sold to cover the option exercise price and required withholding taxes in connection with the exercise of expiring options."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 68 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":7340,"source":{"system":"sec-edgar","filing":"0000318154-26-000129","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000129/form4.xml","form_type":"4"}},{"id":6184,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2026-08-07T22:45:54.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":true,"shares":1000,"price":177.31,"value":177310.0,"ownership":{"direct":true},"balance_after":8340,"source":{"system":"sec-edgar","filing":"0000318154-26-000129","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000129/form4.xml","form_type":"4"}},{"id":6183,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2026-08-07T22:45:54.000Z","date":"2026-08-06","kind":"sale","planned":false,"acquired":false,"shares":1970,"price":402.1601,"value":792255.397,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes shares sold to cover the option exercise price and required withholding taxes in connection with the exercise of expiring options."}],"balance_after":7340,"source":{"system":"sec-edgar","filing":"0000318154-26-000129","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000129/form4.xml","form_type":"4"}},{"id":6182,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2026-08-07T22:45:54.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":true,"shares":1970,"price":177.46,"value":349596.2,"ownership":{"direct":true},"balance_after":9310,"source":{"system":"sec-edgar","filing":"0000318154-26-000129","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000129/form4.xml","form_type":"4"}},{"id":9948,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2026-05-12T00:02:51.000Z","date":"2026-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":88,"price":331.11,"value":29137.68,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 58 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":7330,"source":{"system":"sec-edgar","filing":"0000318154-26-000088","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000088/form4.xml","form_type":"4"}},{"id":10057,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Nqso (Right to Buy)","published_at":"2026-05-08T00:54:27.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":3167,"price":329.59,"value":1043811.53,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/5/2027."}],"balance_after":6334,"derivative":{"exercise_price":329.59,"exercise_date":"2027-05-05","expiration_date":"2036-05-05","underlying":"Common Stock","underlying_shares":3167},"source":{"system":"sec-edgar","filing":"0000318154-26-000076","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000076/form4.xml","form_type":"4"}},{"id":10056,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2026-05-08T00:54:27.000Z","date":"2026-05-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":76,"price":329.59,"value":25048.84,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 68 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":7418,"source":{"system":"sec-edgar","filing":"0000318154-26-000076","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000076/form4.xml","form_type":"4"}},{"id":10055,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2026-05-08T00:54:27.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":485,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/5/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."}],"balance_after":7494,"source":{"system":"sec-edgar","filing":"0000318154-26-000076","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000076/form4.xml","form_type":"4"}},{"id":10288,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2026-05-06T00:09:56.000Z","date":"2026-05-04","kind":"sale","planned":false,"acquired":false,"shares":1237,"price":323.7272,"value":400450.5464,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is an average price of $323.7272 per share. Full information regarding the number of shares purchased at each separate price within the range is available upon request by the SEC staff, the issuer or a security holder of the issuer"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 72 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":7009,"source":{"system":"sec-edgar","filing":"0000318154-26-000064","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000064/form4.xml","form_type":"4"}},{"id":10287,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2026-05-06T00:09:56.000Z","date":"2026-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":116,"price":329.82,"value":38259.12,"ownership":{"direct":true},"balance_after":8246,"source":{"system":"sec-edgar","filing":"0000318154-26-000064","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000064/form4.xml","form_type":"4"}},{"id":10286,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2026-05-06T00:09:56.000Z","date":"2026-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":126,"price":329.82,"value":41557.32,"ownership":{"direct":true},"balance_after":8362,"source":{"system":"sec-edgar","filing":"0000318154-26-000064","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000064/form4.xml","form_type":"4"}},{"id":11784,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2026-03-19T00:34:15.000Z","date":"2026-03-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":787,"price":366.21,"value":288207.27,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 122 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":8488,"source":{"system":"sec-edgar","filing":"0000318154-26-000029","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000029/form4.xml","form_type":"4"}},{"id":12101,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2026-03-06T01:38:47.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":2010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 110 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":9249,"source":{"system":"sec-edgar","filing":"0000318154-26-000018","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000018/form4.xml","form_type":"4"}},{"id":16982,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Nqso (Right to Buy)","published_at":"2025-11-22T01:34:41.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":false,"shares":1639,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":162.6,"exercise_date":"2019-05-01","expiration_date":"2027-05-01","underlying":"Common Stock","underlying_shares":1639},"source":{"system":"sec-edgar","filing":"0000318154-25-000083","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815425000083/form4.xml","form_type":"4"}},{"id":16981,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Nqso (Right to Buy)","published_at":"2025-11-22T01:34:41.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1970,"derivative":{"exercise_price":177.46,"exercise_date":"2020-04-27","expiration_date":"2028-04-27","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0000318154-25-000083","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815425000083/form4.xml","form_type":"4"}},{"id":16980,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2025-11-22T01:34:41.000Z","date":"2025-11-20","kind":"sale","planned":false,"acquired":false,"shares":1639,"price":337.2625,"value":552773.2375,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is an average price. The prices ranged from $337.17 to $337.69 per share. Full information regarding the number of shares purchased at each separate price within the range is available upon request by the SEC staff, the issuer or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 96 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":7225,"source":{"system":"sec-edgar","filing":"0000318154-25-000083","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815425000083/form4.xml","form_type":"4"}},{"id":16979,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2025-11-22T01:34:41.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":true,"shares":1639,"price":162.6,"value":266501.4,"ownership":{"direct":true},"balance_after":8864,"source":{"system":"sec-edgar","filing":"0000318154-25-000083","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815425000083/form4.xml","form_type":"4"}},{"id":16978,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2025-11-22T01:34:41.000Z","date":"2025-11-20","kind":"sale","planned":false,"acquired":false,"shares":1500,"price":337.2625,"value":505893.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is an average price. The prices ranged from $337.17 to $337.69 per share. Full information regarding the number of shares purchased at each separate price within the range is available upon request by the SEC staff, the issuer or a security holder of the issuer."}],"balance_after":7225,"source":{"system":"sec-edgar","filing":"0000318154-25-000083","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815425000083/form4.xml","form_type":"4"}},{"id":16977,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2025-11-22T01:34:41.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":true,"shares":1500,"price":177.46,"value":266190.0,"ownership":{"direct":true},"balance_after":8725,"source":{"system":"sec-edgar","filing":"0000318154-25-000083","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815425000083/form4.xml","form_type":"4"}},{"id":20498,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2025-08-22T23:21:55.000Z","date":"2025-08-20","kind":"sale","planned":false,"acquired":false,"shares":1267,"price":296.985,"value":376279.995,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 80 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":7209,"source":{"system":"sec-edgar","filing":"0000318154-25-000062","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815425000062/form4.xml","form_type":"4"}},{"id":24228,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Nqso (Right to Buy)","published_at":"2025-05-09T00:56:23.000Z","date":"2025-05-06","kind":"grant","planned":false,"acquired":true,"shares":3824,"price":270.44,"value":1034162.56,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/6/2026."}],"balance_after":3824,"derivative":{"exercise_price":270.44,"exercise_date":"2026-05-06","expiration_date":"2035-05-06","underlying":"Common Stock","underlying_shares":3824},"source":{"system":"sec-edgar","filing":"0001127602-25-013783","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760225013783/form4.xml","form_type":"4"}},{"id":24227,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2025-05-09T00:56:23.000Z","date":"2025-05-06","kind":"grant","planned":false,"acquired":true,"shares":591,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/6/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 67 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":8463,"source":{"system":"sec-edgar","filing":"0001127602-25-013783","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760225013783/form4.xml","form_type":"4"}},{"id":24368,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2025-05-07T00:13:08.000Z","date":"2025-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":111,"price":283.78,"value":31499.58,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 67 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":7872,"source":{"system":"sec-edgar","filing":"0001127602-25-013530","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760225013530/form4.xml","form_type":"4"}},{"id":24367,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2025-05-07T00:13:08.000Z","date":"2025-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":118,"price":283.78,"value":33486.04,"ownership":{"direct":true},"balance_after":7983,"source":{"system":"sec-edgar","filing":"0001127602-25-013530","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760225013530/form4.xml","form_type":"4"}},{"id":24465,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2025-05-03T01:28:43.000Z","date":"2025-04-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":113,"price":288.56,"value":32607.28,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 101 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":8101,"source":{"system":"sec-edgar","filing":"0001127602-25-013283","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760225013283/form4.xml","form_type":"4"}},{"id":25600,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2025-03-20T00:19:31.000Z","date":"2025-03-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":524,"price":313.71,"value":164384.04,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 128 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":8214,"source":{"system":"sec-edgar","filing":"0001127602-25-010057","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760225010057/form4.xml","form_type":"4"}},{"id":25975,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2025-03-06T01:06:02.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":1503,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 114 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":8713,"source":{"system":"sec-edgar","filing":"0001127602-25-008425","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760225008425/form4.xml","form_type":"4"}},{"id":28774,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2025-02-07T01:54:37.000Z","date":"2025-02-05","kind":"sale","planned":false,"acquired":false,"shares":1589,"price":304.4731,"value":483807.7559,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 114 Dividend Equivalents (DEs) granted pursuant to the Company's Equity Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":7210,"source":{"system":"sec-edgar","filing":"0001127602-25-003500","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760225003500/form4.xml","form_type":"4"}},{"id":37732,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2024-07-31T23:00:21.000Z","date":"2024-07-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":1565,"price":333.28,"value":521583.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Plan): 199 RSUs which will vest on 4/30/2025; 435 RSUs which will vest in installments of 214 on 5/2/2025, and one installment of 221 on 5/2/2026; 635 RSUs which will vest in installments of 209 on 5/2/2025, 210 on 5/2/2026 and 216 on 5/2/2027; and 499 RSUs which will vest in installments of 164 on 5/7/2026, 165 on 5/7/2027, and 170 on 5/7/2028. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 86 Dividend Equivalents (DEs) granted pursuant to the Company's Equity Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":8771,"source":{"system":"sec-edgar","filing":"0001127602-24-021277","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760224021277/form4.xml","form_type":"4"}},{"id":41072,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Nqso (Right to Buy)","published_at":"2024-05-09T23:05:31.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":3244,"price":300.3,"value":974173.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/7/2026, 5/7/2027 and 5/7/2028, respectively."}],"balance_after":3244,"derivative":{"exercise_price":300.3,"exercise_date":"2026-05-07","expiration_date":"2034-05-07","underlying":"Common Stock","underlying_shares":3244},"source":{"system":"sec-edgar","filing":"0001127602-24-014855","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760224014855/form4.xml","form_type":"4"}},{"id":41071,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2024-05-09T23:05:31.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":499,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/7/2026, 5/7/2027 and 5/7/2028, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,780 RSUs which will vest on 7/31/2024; 199 RSUs which will vest on 4/30/2025; 435 RSUs which will vest in installments of 214 on 5/2/2025, and one installment of 221 on 5/2/2026; 635 RSUs which will vest in installments of 209 on 5/2/2025, 210 on 5/2/2026 and 216 on 5/2/2027; and 499 RSUs which will vest in installments of 164 on 5/7/2026, 165 on 5/7/2027, and 170 on 5/7/2028. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 424 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":10300,"source":{"system":"sec-edgar","filing":"0001127602-24-014855","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760224014855/form4.xml","form_type":"4"}},{"id":41213,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2024-05-08T00:35:25.000Z","date":"2024-05-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":82,"price":311.29,"value":25525.78,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,780 RSUs which will vest on 7/31/2024; 199 RSUs which will vest on 4/30/2025; 435 RSUs which will vest in installments of 214 on 5/2/2025, and one installment of 221 on 5/2/2026; and 635 RSUs which will vest in installments of 209 on 5/2/2025, 210 on 5/2/2026 and 216 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 424 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":9801,"source":{"system":"sec-edgar","filing":"0001127602-24-014509","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760224014509/form4.xml","form_type":"4"}},{"id":41382,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2024-05-03T23:48:03.000Z","date":"2024-05-03","kind":"sale","planned":false,"acquired":false,"shares":2117,"price":313.0853,"value":662801.5801,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is an average price. The prices ranged from $313.071 to $313.0923 per share. Full information regarding the number of shares purchased at each separate price within the range set forth above is available upon request\nby the SEC staff, the issuer or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 144 RSUs which will vest on 5/5/2024; 2,780 RSUs which will vest on 7/31/2024; 199 RSUs which will vest on 4/30/2025; 435 RSUs which will vest in installments of 214 on 5/2/2025, and one installment of 221 on 5/2/2026; and 635 RSUs which will vest in installments of 209 on 5/2/2025, 210 on 5/2/2026 and 216 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 443 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":9883,"source":{"system":"sec-edgar","filing":"0001127602-24-014198","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760224014198/form4.xml","form_type":"4"}},{"id":41386,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2024-05-03T23:22:15.000Z","date":"2024-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":114,"price":277.37,"value":31620.18,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 144 RSUs which will vest on 5/5/2024; 2,780 RSUs which will vest on 7/31/2024; 199 RSUs which will vest on 4/30/2025; 435 RSUs which will vest in installments of 214 on 5/2/2025, and one installment of 221 on 5/2/2026; and 635 RSUs which will vest in installments of 209 on 5/2/2025, 210 on 5/2/2026 and 216 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 443 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":12000,"source":{"system":"sec-edgar","filing":"0001127602-24-014194","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760224014194/form4.xml","form_type":"4"}},{"id":41587,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2024-05-02T00:44:05.000Z","date":"2024-04-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":106,"price":276.38,"value":29296.28,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 144 RSUs which will vest on 5/5/2024; 2,780 RSUs which will vest on 7/31/2024; 199 RSUs which will vest on 4/30/2025; 649 RSUs which will vest in two installments of 214 each on 5/2/2024 and 5/2/2025, and one installment of 221 on 5/2/2026; and 635 RSUs which will vest in installments of 209 on 5/2/2025, 210 on 5/2/2026 and 216 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 457 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":12114,"source":{"system":"sec-edgar","filing":"0001127602-24-013815","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760224013815/form4.xml","form_type":"4"}},{"id":42710,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2024-03-21T00:07:45.000Z","date":"2024-03-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":703,"price":268.87,"value":189015.61,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following RSUs granted under the Company's equity plan: 154 RSUs which will vest on 5/3/2023; 284 RSUs which will vest in installments of 140 on 5/5/2023 and 144 on 5/5/2024; 5,477 RSUs which will vest in installments of 2,697 on 7/31/2023 and 2,780 on 7/31/2024; 584 RSUs which vest in installments of 192 on 4/30/2023, 193 on 4/30/2024 and 199 on 4/30/2025; 468 RSUs which will vest on 11/5/2023; and 649 RSUs which will vest in two installments of 214 on 5/2/2024 and 5/2/2025, and one installment of 221 on 5/2/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 476 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":12220,"source":{"system":"sec-edgar","filing":"0001127602-24-010854","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760224010854/form4.xml","form_type":"4"}},{"id":43697,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2024-03-08T22:29:00.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":1954,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 144 RSUs which will vest on 5/5/2024; 2,780 RSUs which will vest on 7/31/2024; 392 RSUs which will vest in installments of 193 on 4/30/2024 and 199 on 4/30/2025; 649 RSUs which will vest in two installments of 214 each on 5/2/2024 and 5/2/2025, and one installment of 221 on 5/2/2026; and 635 RSUs which will vest in installments of 209 on 5/2/2025, 210 on 5/2/2026 and 216 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 435 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":12866,"source":{"system":"sec-edgar","filing":"0001127602-24-009244","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760224009244/form4.xml","form_type":"4"}},{"id":50196,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2023-12-05T00:41:12.000Z","date":"2023-12-04","kind":"sale","planned":false,"acquired":false,"shares":2096,"price":273.0323,"value":572275.7008,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is an average price. The prices ranged from $273.00 to $273.17 per share. Full information regarding the number of shares purchased at each separate price within the range set forth above is available upon request\nby the SEC staff, the issuer or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 144 RSUs which will vest on 5/5/2024; 2,780 RSUs which will vest on 7/31/2024; 392 RSUs which will vest in installments of 193 on 4/30/2024 and 199 on 4/30/2025; 649 RSUs which will vest in two installments of 214 each on 5/2/2024 and 5/2/2025, and one installment of 221 on 5/2/2026; and 635 RSUs which will vest in installments of 209 on 5/2/2025, 210 on 5/2/2026 and 216 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 397 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":10874,"source":{"system":"sec-edgar","filing":"0001127602-23-028779","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760223028779/form4.xml","form_type":"4"}},{"id":51505,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2023-11-08T01:15:12.000Z","date":"2023-11-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":249,"price":269.86,"value":67195.14,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 144 RSUs which will vest on 5/5/2024; 2,780 RSUs which will vest on 7/31/2024; 392 RSUs which will vest in installments of 193 on 4/30/2024 and 199 on 4/30/2025; 649 RSUs which will vest in two installments of 214 each on 5/2/2024 and 5/2/2025, and one installment of 221 on 5/2/2026; and 635 RSUs which will vest in installments of 209 on 5/2/2025, 210 on 5/2/2026 and 216 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 397 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":12970,"source":{"system":"sec-edgar","filing":"0001127602-23-026976","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760223026976/form4.xml","form_type":"4"}},{"id":54198,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2023-08-01T00:45:14.000Z","date":"2023-07-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":1129,"price":236.37,"value":266861.73,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 144 RSUs which will vest on 5/5/2024; 2,780 RSUs which will vest on 7/31/2024; 392 RSUs which will vest in installments of 193 on 4/30/2024 and 199 on 4/30/2025; 468 RSUs which will vest on 11/5/2023; 649 RSUs which will vest in two installments of 214 on 5/2/2024 and 5/2/2025, and one installment of 221 on 5/2/2026; and 635 RSUs which will vest in installments of 209 on 5/2/2025, 210 on 5/2/2026 and 216 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 304 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":13095,"source":{"system":"sec-edgar","filing":"0001127602-23-021594","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760223021594/form4.xml","form_type":"4"}},{"id":56100,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2023-05-09T23:17:47.000Z","date":"2023-05-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":54,"price":231.89,"value":12522.06,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 144 RSUs which will vest on 5/5/2024; 5,477 RSUs which will vest in installments of 2,697 on 7/31/2023 and 2,780 on 7/31/2024; 392 RSUs which will vest in installments of 193 on 4/30/2024 and 199 on 4/30/2025; 468 RSUs which will vest on 11/5/2023; 649 RSUs which will vest in two installments of 214 on 5/2/2024 and 5/2/2025, and one installment of 221 on 5/2/2026; and 635 RSUs which will vest in installments of 209 on 5/2/2025, 210 on 5/2/2026 and 216 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 571 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":14224,"source":{"system":"sec-edgar","filing":"0001127602-23-015047","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760223015047/form4.xml","form_type":"4"}},{"id":56259,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Nqso (Right to Buy)","published_at":"2023-05-05T00:35:30.000Z","date":"2023-05-02","kind":"grant","planned":false,"acquired":true,"shares":5375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/2/2025, 5/2/2026 and 5/2/2027, respectively."}],"balance_after":5375,"derivative":{"exercise_price":235.97,"exercise_date":"2025-05-02","expiration_date":"2033-05-02","underlying":"Common Stock","underlying_shares":5375},"source":{"system":"sec-edgar","filing":"0001127602-23-014614","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760223014614/form4.xml","form_type":"4"}},{"id":56258,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2023-05-05T00:35:30.000Z","date":"2023-05-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":62,"price":235.97,"value":14630.14,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Company's equity plans: 284 RSUs which will vest in installments of 140 on 5/5/2023 and 144 on 5/5/2024; 5,477 RSUs which will vest in installments of 2,697 on 7/31/2023 and 2,780 on 7/31/2024; 392 RSUs which will vest in installments of 193 on 4/30/2024 and 199 on 4/30/2025; 468 RSUs which will vest on 11/5/2023; 649 RSUs which will vest in two installments of 214 on 5/2/2024 and 5/2/2025, and one installment of 221 on 5/2/2026; and 635 RSUs which will vest in installments of 209 on 5/2/2025, 210 on 5/2/2026 and 216 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 584 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":14278,"source":{"system":"sec-edgar","filing":"0001127602-23-014614","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760223014614/form4.xml","form_type":"4"}},{"id":56257,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2023-05-05T00:35:30.000Z","date":"2023-05-02","kind":"grant","planned":false,"acquired":true,"shares":635,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/2/2025, 5/2/2026 and 5/2/2027, respectively."}],"balance_after":14340,"source":{"system":"sec-edgar","filing":"0001127602-23-014614","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760223014614/form4.xml","form_type":"4"}},{"id":56443,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2023-05-03T00:23:16.000Z","date":"2023-04-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":73,"price":239.74,"value":17501.02,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plan: 154 RSUs which vest in one installment on 5/3/2023; 284 RSUs which vest in installments of 140 on 5/5/2023 and 144 on 5/5/2024; 5,477 RSUs which will vest in installments of 2,697 on 7/31/2023 and 2,780 on 7/31/2024; 392 RSUs which vest in installments of 193 on 4/30/2024 and 199 on 4/30/2025; 468 RSUs which will vest on 11/5/2023; and 649 RSUs which will vest in two installments of 214 on 5/2/2024 and 5/2/2025, and one installment of 221 on 5/2/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 604 DEs granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":13705,"source":{"system":"sec-edgar","filing":"0001127602-23-014153","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760223014153/form4.xml","form_type":"4"}},{"id":57237,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2023-03-20T23:09:39.000Z","date":"2023-03-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":339,"price":234.57,"value":79519.23,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following RSUs granted under the Company's equity plan: 154 RSUs which will vest on 5/3/2023; 284 RSUs which will vest in installments of 140 on 5/5/2023 and 144 on 5/5/2024; 5,477 RSUs which will vest in installments of 2,697 on 7/31/2023 and 2,780 on 7/31/2024; 584 RSUs which vest in installments of 192 on 4/30/2023, 193 on 4/30/2024 and 199 on 4/30/2025; 468 RSUs which will vest on 11/5/2023; and 649 RSUs which will vest in two installments of 214 on 5/2/2024 and 5/2/2025, and one installment of 221 on 5/2/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 616 DEs granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":13778,"source":{"system":"sec-edgar","filing":"0001127602-23-010917","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760223010917/form4.xml","form_type":"4"}},{"id":57596,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2023-03-09T00:09:01.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Company's equity plan: 154 RSUs which will vest on 5/3/2023; 284 RSUs which will vest in installments of 140 on 5/5/2023 and 144 on 5/5/2024; 5,477 RSUs which will vest in installments of 2,697 on 7/31/2023 and 2,780 on 7/31/2024; 584 RSUs which vest in installments of 192 on 4/30/2023, 193 on 4/30/2024 and 199 on 4/30/2025; 468 RSUs which will vest on 11/5/2023; and 649 RSUs which will vest in two installments of 214 on 5/2/2024 and 5/2/2025, and one installment of 221 on 5/2/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 540 DEs granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":14032,"source":{"system":"sec-edgar","filing":"0001127602-23-009500","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760223009500/form4.xml","form_type":"4"}},{"id":61842,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2022-11-08T23:38:57.000Z","date":"2022-11-08","kind":"sale","acquired":false,"shares":545,"price":293.535,"value":159976.575,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Company's equity plan: 154 RSUs which will vest on 5/3/2023; 284 RSUs which will vest in installments of 140 on 5/5/2023 and 144 on 5/5/2024; 5,477 RSUs which will vest in installments of 2,697 7/31/2023 and 2,780 on 7/31/2024; 584 RSUs which vest in installments of 192 on 4/30/2023, 193 on 4/30/2024 and 199 on 4/30/2025; 468 RSUs which will vest on on 11/5/2023; and 649 RSUs which will vest in two installments of 214 on 5/2/2024 and 5/2/2025, and one installment of 221 on 5/2/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 485 DEs granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":13009,"source":{"system":"sec-edgar","filing":"0001127602-22-025154","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760222025154/form4.xml","form_type":"4"}},{"id":61841,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2022-11-08T23:38:57.000Z","date":"2022-11-05","kind":"tax_withholding","acquired":false,"shares":240,"price":269.04,"value":64569.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"240 shares issuable upon the vesting of Restricted Stock Units (RSUs) and related Dividend Equivalents (DEs) on 11/5/2022 were withheld by the Company to cover related tax withholding obligations."}],"balance_after":13554,"source":{"system":"sec-edgar","filing":"0001127602-22-025154","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760222025154/form4.xml","form_type":"4"}},{"id":64709,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2022-08-03T01:22:37.000Z","date":"2022-07-31","kind":"tax_withholding","acquired":false,"shares":1229,"price":247.47,"value":304140.63,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plan: 154 RSUs which vest in one installment on 5/3/2023; 284 RSUs which vest in installments of 140 on 5/5/2023 and 144 on 5/5/2024; 5,477 RSUs which will vest in installments of 2,697 on 7/31/2023 and 2,780 on 7/31/2024; 584 RSUs which vest in installments of 192 on 4/30/2023, 193 on 4/30/2024 and 199 on 4/30/2025; 935 RSUs which will vest in installments of 467 on 11/5/2022 and 468 on 11/5/2023; and 649 RSUs which will vest in two installments of 214 on 5/2/2024 and 5/2/2025, and one installment of 221 on 5/2/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 434 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":13728,"source":{"system":"sec-edgar","filing":"0001127602-22-020302","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760222020302/form4.xml","form_type":"4"}},{"id":66496,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2022-05-09T23:07:01.000Z","date":"2022-05-05","kind":"tax_withholding","acquired":false,"shares":52,"price":236.1,"value":12277.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plan: 154 RSUs which vest on 5/3/2023; 284 RSUs which vest in one installment of 140 on 5/5/2023 and one installment of 144 on 5/5/2024; 8,174 RSUs which will vest in two installments of 2,697 on 7/31/2022 and 7/31/2023 and one installment of 2,780 on 7/31/2024; 584 RSUs which vest in installments of 192 on 4/30/2023, 193 on 4/30/2024 and 199 on 4/30/2025; 935 RSUs which will vest in installments of 467 on 11/5/2022 and 468 on 11/5/2023; and 649 RSUs which will vest in two installments of 214 on 5/2/2024 and 5/2/2025, and one installment of 221 on 5/2/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 515 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":14869,"source":{"system":"sec-edgar","filing":"0001127602-22-013872","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760222013872/form4.xml","form_type":"4"}},{"id":66656,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Nqso (Right to Buy)","published_at":"2022-05-04T23:57:26.000Z","date":"2022-05-02","kind":"grant","acquired":true,"shares":5302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/2/2024, 5/2/2025 and 5/2/2026, respectively."}],"balance_after":5302,"derivative":{"exercise_price":230.92,"exercise_date":"2024-05-02","expiration_date":"2032-05-02","underlying":"Common Stock","underlying_shares":5302},"source":{"system":"sec-edgar","filing":"0001127602-22-013347","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760222013347/form4.xml","form_type":"4"}},{"id":66655,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2022-05-04T23:57:26.000Z","date":"2022-05-02","kind":"tax_withholding","acquired":false,"shares":57,"price":230.92,"value":13162.44,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Company's equity plan: 154 RSUs which vest in one installment of 154 on 5/3/2023; 423 RSUs which vest in installments of 139 on 5/5/2022, 140 on 5/5/2023 and 144 on 5/5/2024; 8,174 RSUs which will vest in two installments of 2,697 on 7/31/2022 and 7/31/2023 and one installment of 2,780 on 7/31/2024; 584 RSUs which vest in installments of 192 on 4/30/2023, 193 on 4/30/2024 and 199 on 4/30/2025; 935 RSUs which will vest in installments of 467 on 11/5/2022 and 468 on 11/5/2023; and 649 RSUs which will vest in two installments of 214 on 5/2/2024 and 5/2/2025, and one installment of 221 on 5/2/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 523 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":14921,"source":{"system":"sec-edgar","filing":"0001127602-22-013347","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760222013347/form4.xml","form_type":"4"}},{"id":66654,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2022-05-04T23:57:26.000Z","date":"2022-05-02","kind":"grant","acquired":true,"shares":649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/2/2024, 5/2/2025 and 5/2/2026, respectively."}],"balance_after":14978,"source":{"system":"sec-edgar","filing":"0001127602-22-013347","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760222013347/form4.xml","form_type":"4"}},{"id":66878,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2022-04-29T22:41:42.000Z","date":"2022-04-27","kind":"tax_withholding","acquired":false,"shares":60,"price":249.87,"value":14992.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following RSUs granted under the Company's equity plans: 452 RSUs which will vest in one installment on 5/3/2022 and one installment of 154 on 5/3/2023; 423 RSUs which vest in installments of 139 on 5/5/2022, 140 on 5/5/2023 and 144 on 5/5/2024; 8,174 RSUs which will vest in two installments of 2,697 on 7/31/2022 and 7/31/2023 and one installment of 2,780 on 7/31/2024; and 935 RSUs which will vest in installments of 467 on 11/5/2022 and 468 on 11/5/2023. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 536 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":14329,"source":{"system":"sec-edgar","filing":"0001127602-22-012761","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760222012761/form4.xml","form_type":"4"}},{"id":68318,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2022-03-22T21:41:14.000Z","date":"2022-03-18","kind":"tax_withholding","acquired":false,"shares":350,"price":235.86,"value":82551.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following RSUs granted under the Company's equity plans: 153 RSUs which will vest on 4/27/2022; 303 RSUs which vest in installments of 149 on 5/3/2022 and 154 on 5/3/2023; 423 RSUs which vest in installments of 139 on 5/5/2022, 140 on 5/5/2023 and 144 on 5/5/2024; 8,174 RSUs which will vest in two installments of 2,697 on 7/31/2022 and 7/31/2023 and one installment of 2,780 on 7/31/2024; 584 RSUs which vest in installments of 192 on 4/30/2023, 193 on 4/30/2024 and 199 on 4/30/2025; and 935 RSUs which will vest in installments of 467 on 11/5/2022 and 468 on 11/5/2023. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 555 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":14389,"source":{"system":"sec-edgar","filing":"0001127602-22-010191","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760222010191/form4.xml","form_type":"4"}},{"id":69579,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2022-03-04T00:28:50.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":1001,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following RSUs granted under the Company's equity plans: 153 RSUs which will vest on 4/27/2022; 303 RSUs which vest in installments of 149 on 5/3/2022 and 154 on 5/3/2023; 423 RSUs which vest in installments of 139 on 5/5/2022, 140 on 5/5/2023 and 144 on 5/5/2024; 8,174 RSUs which will vest in two installments of 2,697 on 7/31/2022 and 7/31/2023 and one installment of 2,780 on 7/31/2024; 584 RSUs which vest in installments of 192 on 4/30/2023, 193 on 4/30/2024 and 199 on 4/30/2025; and 935 RSUs which will vest in installments of 467 on 11/5/2022 and 468 on 11/5/2023. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 462 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":14638,"source":{"system":"sec-edgar","filing":"0001127602-22-008134","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760222008134/form4.xml","form_type":"4"}},{"id":77236,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2021-11-10T01:12:24.000Z","date":"2021-11-05","kind":"grant","acquired":true,"shares":935,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in two annual installments of 50% on 11/5/2022 and 11/5/2023, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Company's equity plans: 153 RSUs which will vest on 4/27/2022; 452 RSUs which will vest in one installment on 5/3/2022 and one installment of 154 on 5/3/2023; 423 RSUs which vest in installments of 139 on 5/5/2022, 140 on 5/5/2023 and 144 on 5/5/2024; 8,174 RSUs which will vest in two installments of 2,697 on 7/31/2022 and 7/31/2023 and one installment of 2,780 on 7/31/2024; and 935 RSUs which will vest in installments of 467 on 11/5/2022 and 468 on 11/5/2023. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 372 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":13547,"source":{"system":"sec-edgar","filing":"0001127602-21-028756","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760221028756/form4.xml","form_type":"4"}},{"id":87802,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Nqso (Right to Buy)","published_at":"2021-05-13T00:10:20.000Z","date":"2021-05-11","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1639,"derivative":{"exercise_price":162.6,"exercise_date":"2019-05-01","expiration_date":"2027-05-01","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001127602-21-016446","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760221016446/form4.xml","form_type":"4"}},{"id":87801,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2021-05-13T00:10:20.000Z","date":"2021-05-11","kind":"sale","acquired":false,"shares":2500,"price":252.5089,"value":631272.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is an average price. The prices ranged from $252.33 to $252.69 per share for this cashless exercise of 2,500 stock options expiring May 1, 2027. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Company's equity plans: 153 RSUs which will vest on 4/27/2022; 303 RSUs which vest in installments of 149 on 5/3/2022 and 154 on 5/3/2023; 423 RSUs which vest in installments of 139 on 5/5/2022, 140 on 5/5/2023 and 144 on 5/5/2024; 8,174 RSUs which will vest in two installments of 2,697 on 7/31/2022 and 7/31/2023 and one installment of 2,780 on 7/31/2024; and 584 RSUs which vest in installments of 192 on 4/30/2023, 193 on 4/30/2024 and 199 on 4/30/2025. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 221 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":12461,"source":{"system":"sec-edgar","filing":"0001127602-21-016446","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760221016446/form4.xml","form_type":"4"}},{"id":87800,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2021-05-13T00:10:20.000Z","date":"2021-05-11","kind":"exercise","acquired":true,"shares":2500,"price":162.6,"value":406500.0,"ownership":{"direct":true},"balance_after":14961,"source":{"system":"sec-edgar","filing":"0001127602-21-016446","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760221016446/form4.xml","form_type":"4"}},{"id":88900,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Nqso (Right to Buy)","published_at":"2021-05-04T23:21:16.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":5072,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 4/30/2023, 4/30/2024 and 4/30/2025, respectively."}],"balance_after":5072,"derivative":{"exercise_price":239.64,"exercise_date":"2023-04-30","expiration_date":"2031-04-30","underlying":"Common Stock","underlying_shares":5072},"source":{"system":"sec-edgar","filing":"0001127602-21-015358","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760221015358/form4.xml","form_type":"4"}},{"id":88899,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2021-05-04T23:21:16.000Z","date":"2021-05-03","kind":"tax_withholding","acquired":false,"shares":55,"price":239.64,"value":13180.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Company's equity plans: 153 RSUs which will vest on 4/27/2022; 303 RSUs which vest in installments of 149 on 5/3/2022 and 154 on 5/3/2023; 423 RSUs which vest in installments of 139 on 5/5/2022, 140 on 5/5/2023 and 144 on 5/5/2024; 8,174 RSUs which will vest in two installments of 2,697 on 7/31/2022 and 7/31/2023 and one installment of 2,780 on 7/31/2024; and 584 RSUs which vest in installments of 192 on 4/30/2023, 193 on 4/30/2024 and 199 on 4/30/2025. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 221 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":12461,"source":{"system":"sec-edgar","filing":"0001127602-21-015358","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760221015358/form4.xml","form_type":"4"}},{"id":88898,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2021-05-04T23:21:16.000Z","date":"2021-05-01","kind":"tax_withholding","acquired":false,"shares":62,"price":239.64,"value":14857.68,"ownership":{"direct":true},"balance_after":12516,"source":{"system":"sec-edgar","filing":"0001127602-21-015358","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760221015358/form4.xml","form_type":"4"}},{"id":88897,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2021-05-04T23:21:16.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":584,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/30/2023, 4/30/2024 and 4/30/2025, respectively."}],"balance_after":12578,"source":{"system":"sec-edgar","filing":"0001127602-21-015358","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760221015358/form4.xml","form_type":"4"}},{"id":89164,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2021-04-29T00:05:15.000Z","date":"2021-04-27","kind":"tax_withholding","acquired":false,"shares":57,"price":255.52,"value":14564.64,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 159 RSUs which will vest on 5/1/2021; 153 RSUs which will vest on 4/27/2022; 452 RSUs which vest in two installments of 149 on 5/3/2021 and 5/3/2022 and one installment of 154 on 5/3/2023; 423 RSUs which vest in installments of 139 on 5/5/2022, 140 on 5/5/2023 and 144 on 5/5/2024; and 8,174 RSUs which will vest in two installments of 2,697 on 7/31/2022 and 7/31/2023 and one installment of 2,780 on 7/31/2024. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 247 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":11994,"source":{"system":"sec-edgar","filing":"0001127602-21-014599","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760221014599/form4.xml","form_type":"4"}},{"id":90727,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2021-03-22T22:28:34.000Z","date":"2021-03-19","kind":"tax_withholding","acquired":false,"shares":435,"price":244.42,"value":106322.7,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 159 RSUs which fully vest on 5/1/2021; 302 RSUs which vest in installments of 149 on 4/27/2021 and 153 on 4/27/2022; 452 RSUs which vest in two installments of 149 on 5/3/2021 and 5/3/2022 and one installment of 154 on 5/3/2023; 423 RSUs which vest in installments of 139 on 5/5/2022, 140 on 5/5/2023 and 144 on 5/5/2024; and 8,174 RSUs which will vest in two installments of 2,697 on 7/31/2022 and 7/31/2023 and one installment of 2,780 on 7/31/2024. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 260 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":12051,"source":{"system":"sec-edgar","filing":"0001127602-21-011711","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760221011711/form4.xml","form_type":"4"}},{"id":91658,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2021-03-05T01:27:14.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":1245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 159 RSUs which fully vest on 5/1/2021; 302 RSUs which vest in installments of 149 on 4/27/2021 and 153 on 4/27/2022; 452 RSUs which vest in two installments of 149 on 5/3/2021 and 5/3/2022 and one installment of 154 on 5/3/2023; 423 RSUs which vest in installments of 139 on 5/5/2022, 140 on 5/5/2023 and 144 on 5/5/2024; and 8,174 RSUs which will vest in two installments of 2,697 on 7/31/2022 and 7/31/2023 and one installment of 2,780 on 7/31/2024. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 185 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":12401,"source":{"system":"sec-edgar","filing":"0001127602-21-009479","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760221009479/form4.xml","form_type":"4"}},{"id":102856,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2020-08-03T22:46:40.000Z","date":"2020-08-03","kind":"tax_withholding","acquired":false,"shares":290,"price":244.67,"value":70954.3,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 159 RSUs which fully vest on 5/1/2021; 302 RSUs which vest in installments of 149 on 4/27/2021 and 153 on 4/27/2022; 452 RSUs which vest in two installments of 149 on 5/3/2021 and 5/3/2022 and one installment of 154 on 5/3/2023; 423 RSUs which vest in installments of 139 on 5/5/2022, 140 on 5/5/2023 and 144 on 5/5/2024; and 8,174 RSUs which will vest in two installments of 2,697 on 7/31/2022 and 7/31/2023 and one installment of 2,780 on 7/31/2024. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 55 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":11026,"source":{"system":"sec-edgar","filing":"0001127602-20-022624","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760220022624/form4.xml","form_type":"4"}},{"id":102855,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2020-08-03T22:46:40.000Z","date":"2020-07-31","kind":"grant","acquired":true,"shares":8174,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11316,"source":{"system":"sec-edgar","filing":"0001127602-20-022624","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760220022624/form4.xml","form_type":"4"}}]}